Family-based case-control study of cigarette smoking and Parkinson disease

Neurology

Volumn 64, Issue 3, 2005, Pages 442-447

  Scott, W K ^a,b   Zhang, F ^a   Stajich, J M ^a   Scott, B L ^a   Stacy, M A ^a   Vance, J M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; COMPARATIVE STUDY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FAMILY; FEMALE; GENDER; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SIBLING; TELEPHONE;

EID: 13244287690     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000150905.93241.B2     Document Type: Article

References (21)

1. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002;52:276-284.
2. Kelada SN, Costa-Mallen P, Costa LG, et al. Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease. Neurotoxicology 2002;23:515-519.
3. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT, Jr., Swanson PD. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002;155:732-738.
4. Levecque C, Elbaz A, Clavel J, et al. Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study. Hum Mol Genet 2003;12:79-86.
5. Witte JS, Gauderman WJ, Thomas DC. Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Am J Epidemiol 1999;149:693-705.
6. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63:259-266.
7. Boehnke M, Cox NJ. Accurate inference of relationships in sib-pair linkage studies. Am J Hum Genet 1997;61:423-429.
8. Gauderman WJ. Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 2002;21:35-50.
9. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. Adv Neurol 1990;53:245-249.
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
11. Hughes AJ, Ben Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42:1142-1146.
12. Reider CR, Halter CA, Castelluccio PF, Oakes D, Nichols WC, Foroud T. Reliability of reported age at onset for Parkinson's disease. Mov Disord 2003;18:275-279.
13. Benedetti MD, Bower JH, Maraganore DM, et al. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology 2000;55:1350-1358.
14. Tanner CM, Goldman SM, Aston DA, et al. Smoking and Parkinson's disease in twins. Neurology 2002;58:581-588.
15. Cheng LS, Swan GE, Carmelli D. A genetic analysis of smoking behavior in family members of older adult males. Addiction 2000;95:427-435.
16. Liou HH, Tsai MC, Chen CJ, et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997;48:1583-1588.
17. Gorell JM, Rybicki BA, Johnson CC, Peterson EL. Smoking and Parkinson's disease: a dose-response relationship. Neurology 1999;52:115-119.
18. Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry 1998;64:314-319.
19. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
20. Castagnoli K, Murugesan T. Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links? Neurotoxicology 2004;25:279-291.
21. Elbaz A, Manubens-Bertran JM, Baldereschi M, et al. Parkinson's disease, smoking, and family history. EUROPARKINSON Study Group. J Neurol 2000;247:793-798.